You need a medication. Your doctor prescribes it. And then your pharmacy tells you it is not covered without extra paperwork. Welcome to prior authorization for medication — a process that affects one in four prescription claims in the United States, according to the American Medical Association. While the process can feel like an obstacle, understanding how it works and what your doctor needs to submit can mean the difference between days and weeks of waiting.
Why Medications Require Prior Authorization
Prior authorization is a cost-control tool used by health insurers and pharmacy benefit managers (PBMs). Before your plan agrees to pay for certain drugs, it requires your prescribing doctor to submit evidence that the medication is medically necessary and that less expensive alternatives are not appropriate.
Not every medication requires prior authorization. The drugs most commonly flagged include new brand-name medications with existing generic alternatives, specialty drugs costing thousands per month, medications with significant safety risks or abuse potential, and drugs where clinical guidelines recommend trying a first-line therapy before moving to a more expensive option.
Your PBM — whether it is Express Scripts, CVS Caremark, or OptumRx — establishes the prior authorization criteria based on clinical evidence, FDA labeling, and cost considerations. The criteria spell out exactly what documentation the prescriber must provide.
Step-by-Step: How Prior Authorization Works
The process follows a predictable path, though timelines vary by plan and urgency level.
1. Prescription submission and rejection. You bring your prescription to the pharmacy. The pharmacist submits the claim electronically, and the PBM’s system returns a rejection code indicating prior authorization is required. The pharmacist notifies you and may provide a reference number.
2. Prescriber receives notification. The PBM sends a notification to your doctor’s office — either electronically or by fax — with the prior authorization form and coverage criteria. Some PBMs offer electronic PA (ePA) systems that allow the prescriber to submit the request in real time during the office visit.
3. Documentation submission. Your doctor’s office completes the PA form, including your diagnosis, relevant lab results, medications you have previously tried (and why they did not work), and a statement of medical necessity. Thorough documentation at this stage is critical. Incomplete forms are the leading cause of delays and denials.
4. PBM review. A clinical pharmacist or medical director at the PBM reviews the submission against the plan’s coverage criteria. Standard reviews take 2 to 5 business days. Urgent requests — where delaying the medication could cause serious harm — are expedited, with decisions typically within 24 to 72 hours.
5. Decision notification. The PBM notifies both your doctor and you of the decision: approved, denied, or approved with modifications (such as a different dosage or quantity). Approvals are typically valid for 6 to 12 months, after which a renewal request is required.
What Documentation Strengthens a Prior Authorization Request
The strength of the submission directly correlates with the likelihood of approval. Here is what makes a prior authorization for medication request compelling:
Complete treatment history. List every medication you have tried for the condition, including dosages and durations. Document why each was discontinued — whether due to lack of effectiveness, side effects, allergic reactions, or drug interactions. PBMs want to see that cheaper alternatives were given a fair trial.
Objective clinical data. Lab results, imaging, and clinical measurements strengthen the case. For a biologic requested for rheumatoid arthritis, include disease activity scores, inflammatory markers (CRP, ESR), and joint imaging. For a specialty cancer drug, include pathology reports and genetic testing results.
Clear medical necessity statement. Your doctor should explain why this specific medication — and not an alternative — is the right choice for your situation. Generic statements like “patient needs this drug” are less effective than detailed clinical reasoning.
Supporting clinical literature. For off-label uses or newer medications, peer-reviewed studies from PubMed or professional society guidelines can bolster the request. If a medication is recommended by an organization like the American College of Rheumatology or the National Comprehensive Cancer Network, citing that guideline helps.
What to Do If Prior Authorization Is Denied
A denial is not the end. According to AMA survey data, a substantial percentage of prior authorization denials are overturned on appeal. You have both the right and the tools to fight a denial.
Understand the denial reason. The PBM must provide a written explanation. Common reasons include insufficient documentation, failure to try a required step therapy drug, diagnosis not meeting coverage criteria, or the medication being excluded from the formulary entirely.
First-level appeal. Your doctor submits additional clinical documentation addressing the specific denial reason. If the denial was based on missing information, providing that information may resolve the issue immediately. If it was based on step therapy requirements, documenting why the required first-line drugs are not appropriate for your case is essential.
External review. If the internal appeal is denied, most plans offer an external review by an independent third party. This reviewer is not affiliated with your insurer or PBM and evaluates the case on its clinical merits. External reviews are particularly effective for complex cases where the treating specialist has strong clinical justification.
State insurance department. If you believe the denial violates state law or your plan’s coverage terms, you can file a complaint with your state’s department of insurance. Some states have specific protections for certain types of prior authorization denials.
Electronic Prior Authorization: A Faster Path
Traditional prior authorization involves faxed forms, phone calls, and multi-day waits. Electronic prior authorization (ePA) is changing that. Through ePA systems, prescribers can submit PA requests directly from their electronic health record (EHR) during the patient visit. The PBM’s system evaluates the request in real time, sometimes returning an approval before the patient leaves the office.
The CMS Interoperability and Prior Authorization Final Rule requires Medicare Advantage and Medicaid plans to implement electronic PA by 2026. Commercial plans are adopting ePA systems voluntarily, driven by efficiency gains and competitive pressure.
Not all medications or plans are integrated into ePA systems yet. Ask your doctor’s office whether they can submit the request electronically. If so, the process may be resolved within hours rather than days.
Prior Authorization for Specific Medication Categories
GLP-1 medications (Ozempic, Wegovy, Mounjaro): These high-demand drugs almost universally require prior authorization. Insurers typically require documentation of a diabetes or obesity diagnosis, failed lifestyle interventions, and sometimes BMI criteria. Coverage varies significantly by plan — check our guide on Medicare coverage of Wegovy for program-specific details.
Biologics: Nearly all biologics require PA. Plans typically mandate step therapy through conventional treatments before approving a biologic. Biosimilars — FDA-approved copies of biologic drugs — may have fewer PA requirements than reference biologics.
Controlled substances: Opioids and benzodiazepines frequently require PA, especially for quantities above recommended thresholds. Documentation should include a pain management plan, risk assessment, and evidence of monitoring (such as prescription drug monitoring program checks).
Specialty medications: Drugs dispensed through specialty pharmacies like OptumRx specialty pharmacy almost always require prior authorization due to their high cost and complex clinical profiles.
Frequently Asked Questions
How long does prior authorization for medication take?
Standard requests take 2 to 5 business days. Urgent requests are processed within 24 to 72 hours. Medicare Part D plans must respond within 72 hours for standard and 24 hours for urgent requests. Delays most commonly result from incomplete submissions or difficulty reaching the prescriber for additional information.
Can I get a temporary supply while waiting for prior authorization?
Many plans allow a one-time emergency supply — typically 72 hours to 30 days — to bridge the gap while the PA is pending. Ask your pharmacist about an emergency supply override. Medicare Part D plans are required to offer a temporary supply in transition situations.
Does prior authorization apply to generic medications?
Rarely. Most generic medications are on the formulary without PA requirements. However, some generics may require PA if they are used for off-label indications, exceed standard quantities, or are new to the market without an established utilization history.
Who is responsible for submitting the prior authorization?
Your prescribing doctor’s office is responsible for submitting the PA request and supporting documentation. You can help by providing your insurance information, following up with the doctor’s office to ensure the request has been submitted, and checking with the PBM on the status.
Taking Control of the Process
Waiting for prior authorization for medication is frustrating, but passivity makes it worse. Ask your doctor to check PA requirements before prescribing. If PA is needed, confirm the submission within 24 hours. Follow up with both your doctor’s office and the PBM every 48 hours until you have a decision. And if you are denied, appeal — the data supports persistence.
For more on how prior authorization fits into the broader healthcare benefits landscape, including PBM reform efforts that aim to streamline the process, visit our healthcare policy guide.